The Second Chance for Moms Act of 2025 mandates a warning label on mifepristone and establishes a hotline for women seeking to reverse its effects.
The Second Chance for Moms Act of 2025 amends the Federal Food, Drug, and Cosmetic Act to require a warning label on mifepristone stating that its abortifacient effects can be counteracted by natural progesterone. The Public Health Service Act is amended to create a 24/7 toll-free hotline for women seeking to reverse the effects of mifepristone, with referrals only to providers offering abortion pill reversal services. The changes take effect six months after the act's enactment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.